GRAIL Inc (NASDAQ: GRAL) started the day on Thursday, with a price decrease of -6.98% at $97.44, before settling in for the price of $104.75 at the close. Taking a more long-term approach, GRAL posted a 52-week range of $16.56-$115.76.
The Healthcare sector firm’s twelve-monthly sales growth has been -89.93% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -89.93%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 81.26%. This publicly-traded company’s shares outstanding now amounts to $36.16 million, simultaneously with a float of $34.01 million. The organization now has a market capitalization sitting at $3.80 billion.
GRAIL Inc (GRAL) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. GRAIL Inc’s current insider ownership accounts for 12.75%, in contrast to 66.09% institutional ownership. According to the most recent insider trade that took place on Dec 03 ’25, this organization’s President sold 13,000 shares at the rate of 100.00, making the entire transaction reach 1,300,000 in total value, affecting insider ownership by 368,818. Preceding that transaction, on Dec 03 ’25, Company’s Chief Executive Officer sold 40,000 for 95.24, making the whole transaction’s value amount to 3,809,535. This particular insider is now the holder of 688,029 in total.
GRAIL Inc (GRAL) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.72 per share during the current fiscal year.
GRAIL Inc’s EPS increase for this current 12-month fiscal period is 81.26% and is forecasted to reach -11.54 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 43.67% through the next 5 years, which can be compared against the -89.93% growth it accomplished over the previous five years trading on the market.
GRAIL Inc (NASDAQ: GRAL) Trading Performance Indicators
Let’s observe the current performance indicators for GRAIL Inc (GRAL). It’s Quick Ratio in the last reported quarter now stands at 7.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 26.78.
In the same vein, GRAL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -11.61, a figure that is expected to reach -3.15 in the next quarter, and analysts are predicting that it will be -11.54 at the market close of one year from today.
